جستجوی استاد راهنمای دانشگاهی

Shaji K Chackoمشاهده پروفایل

دانشگاهی

• Glucose Metabolism
• Gluconeogenesis
• Glycogenolysis
• +۱۲ مورد دیگر

Shaji K Chacko, Ph.D., is an Instructor in the Department of Pediatrics – Nutrition at Baylor College of Medicine, where he leads an independent research laboratory at the USDA/ARS Children's Nutrition Research Center in Houston, Texas. His work focuses on metabolic regulation, particularly glucose production pathways in health and disease. BS, Nagpur University (1990) MS, Barkatullah University (1992) MS, University of Houston, Clear Lake (2000) PhD, University of Groningen (2011) Dr. Chacko's research centers on glucose metabolism , specifically gluconeogenesis and glycogenolysis , using stable isotope tracers and mass spectrometry. His lab investigates metabolic dysfunctions in conditions such as insulin resistance, type 2 diabetes, and post-surgical states, with a strong focus on pediatric and neonatal populations. He also studies total energy expenditure using the doubly labeled water method in free-living subjects. The 15 most recent publications reflect a consistent focus on metabolic regulation, particularly in insulin resistance , obesity , diabetes , and parenteral nutrition . Key themes include hormonal regulation (e.g., leptin), amino acid metabolism (glycine, BCAA), liver function, and therapeutic interventions like metformin and nutritional supplements. His work frequently involves translational models, including human clinical studies and genetically modified animal models. Dr. Chacko has not received any explicitly mentioned scientific awards in the provided texts. He mentors lab members such as Zhensheng Chen (Research Associate) and collaborates extensively with clinicians and scientists, including M.W. Haymond and F. Jahoor. While no specific grants are listed, his research likely involves externally funded projects given the scope and equipment required for stable isotope and mass spectrometry studies. His lab benefits from the state-of-the-art facilities at the Children's Nutrition Research Center, including a metabolic kitchen, greenhouse, and advanced instrumentation. The Shaji Chacko Lab is embedded within the USDA/ARS Children's Nutrition Research Center, a multidisciplinary hub housing elite scientists conducting cutting-edge research in pediatric nutrition and metabolism. The center provides extensive resources including specialized laboratories, research accommodations, and a collaborative scientific environment.

• Metabolic Syndrome
• Type 2 Diabetes
• Insulin/IGF-I Signaling Pathway
• +۱۲ مورد دیگر

J.A.M.J.L. Janssen is a Researcher in the Department of Internal Medicine at Erasmus MC, a leading academic medical center in the Netherlands. The research profile indicates active contributions to the fields of endocrinology, metabolism, and molecular medicine. The research interests of J.A.M.J.L. Janssen center on metabolic syndrome , type 2 diabetes , ectopic fat deposition , hyperinsulinemia , and the insulin/IGF-I signaling pathway . Additional focus includes receptor pharmacology , particularly the interplay between IGF-I and TSH receptors in thyroid eye disease. Research also extends to overnutrition , ultra-processed foods , and the metabolic consequences of Westernization. These interests are reflected in a high volume of recent review articles and commentaries in prominent journals. The recent publications demonstrate a strong trend toward synthesizing evidence on metabolic dysregulation, advocating for paradigm shifts in diabetes management, and exploring molecular mechanisms of disease. Work frequently appears in journals such as International Journal of Molecular Sciences and The Lancet Regional Health - Europe , indicating high impact and policy relevance. While no specific scientific awards are listed in the provided text, the research has been cited extensively (e.g., 38 citations for a 2022 article) and picked up by multiple news outlets and blogs, suggesting recognition in both academic and public spheres. J.A.M.J.L. Janssen has supervised at least three research projects, as indicated by the 'Supervised Work (3)' metric, though specific student names and grant details are not available. The scholarly output includes collaborations with international researchers, such as L. Girnita and T.J. Smith. The research is conducted within the Department of Internal Medicine at Erasmus MC, with no additional lab or team structure described in the text.

• Cosmetic Science
• Pharmaceutics
• Dermatology
• +۴ مورد دیگر

Dr. Deborah A. Kayode serves as Assistant Professor of Pharmaceutics and Industrial Science and Full-time Director of Cosmetic Science at Long Island University, specializing in evidence-based cosmetic product development with particular expertise in cellulite pathophysiology and formulation science. Her academic credentials include: Ph.D. in Cosmetic Science, University of Sunderland (2021) M.Sc. in Drug Discovery and Development, University of Sunderland (2015) PGDip. in Clinical Pharmacology, University of Aberdeen (2014) B.Sc. in Biochemistry, Ajayi Crowther University (2012) Dr. Kayode's research program centers on the human integumentary system with emphasis on gynoid lipodystrophy mechanisms and novel anti-cellulite treatments. She pioneers rheological characterization techniques for cosmetic formulations while developing innovative quality control methodologies that bridge laboratory testing with consumer sensory experiences. Her work establishes scientific foundations for cosmetic claim substantiation through rigorous in vivo validation protocols. Analysis of her publication record reveals consistent advancement in cosmetic formulation science, particularly regarding oil-in-water emulsion systems. Her research demonstrates sophisticated integration of rheological analysis with sensory evaluation, develops stability assessment frameworks for natural oil-containing products, and creates novel quality control metrics linking refractive index measurements to skin hydration outcomes - collectively enhancing scientific rigor in cosmetic product development. Dr. Kayode has mentored 15 undergraduate and master's students through research projects while maintaining significant industry engagement through product validation services for cosmetic and pharmaceutical companies. Her notable BBC collaboration on The Truth About...Looking Good featured rigorous in vivo testing of anti-cellulite treatments, demonstrating real-world application of her research methodology. She additionally established comprehensive quality assurance guidelines for laboratory operations and continues to lead the Cosmetic Science program as Director.

• Bone Metabolism
• Kidney Disease
• Transcriptional Regulation
• +۵ مورد دیگر

Jackie A. Fretz, PhD, is a Researcher at Yale University's Yale School of Medicine, affiliated with the Department of Orthopaedics & Rehabilitation. She manages the Histology and Histomorphometry Laboratory and holds a PhD from the University of Wisconsin-Madison. Her research focuses on the transcription factor EBF1's role in cellular fate determination, particularly in bone, kidney, and adipocyte biology. She investigates how EBF1 regulates mesenchymal progenitors, marrow adipogenesis, and kidney glomerular development. Education: PhD in Biochemistry (University of Wisconsin-Madison, 2007); BS in Biochemistry and Molecular Biology (University of New Hampshire, 2002). Postdoctoral training at Yale School of Medicine (2011). Research interests include EBF1's actions in bone vasculature, renal pathophysiology, and metabolic pathways. Her work bridges bone and kidney diseases, revealing conserved mechanisms in mesenchymal cell regulation. Recent studies explore EBF1's role in fracture repair, chronic kidney disease-mineral bone disorders, and FGF23 regulation. Awards include the ASBMR Mid-Career Travel Grant (2022) and the American Society of Bone and Mineral Research President's Poster Award (2011). She has presented at international conferences such as the ASBMR Annual Meeting and the NIH Workshop on FGF-23. Laboratory: Orthopaedic Histology and Histomorphometry Laboratory, focused on histological techniques and skeletal research. Active in methodological advancements like methyl methacrylate embedding for bone analysis.

Maria Bohnertمشاهده پروفایل

استاد

• Cell Biology
• Molecular Biology
• Biochemistry
• +۳ مورد دیگر

Maria Bohnert serves as Professor at the Institute of Cell Dynamics and Imaging within the Medical Faculty of the University of Münster, where she leads the Bohnert Lab focused on organelle communication and cellular lipid homeostasis. Appointed as Gerty Cori Group leader since September 2018, she actively supervises students through the CiM-IMPRS Graduate Programme and contributes to the Cells in Motion interdisciplinary research cluster. Her academic foundation includes: 2002-2007: Diplom in Molecular Medicine (Dipl.Mol.Med.) from University of Freiburg 2007-2011: Doctor rerum naturalium (Dr.rer.nat) from University of Freiburg 2012-2015: Postdoctoral research at University of Freiburg 2015-2018: Postdoctoral research at Weizmann Institute of Science, Israel Bohnert's research program centers on lipid droplet (LD) dynamics and inter-organelle communication, employing robotic high-throughput microscopy screening to identify molecular players in LD contact sites. Her lab investigates how specialized molecular machines physically link organelles to exchange material and information, with particular focus on LD dysfunction in obesity, diabetes, lipodystrophy, and neurological disorders. This work bridges fundamental cell biology with translational implications for metabolic diseases. Analysis of her recent publications (2020-2025) reveals consistent investigation of organelle contact sites across multiple model systems, with predominant emphasis on lipid droplet interactions with peroxisomes, mitochondria, and vacuoles. Key thematic threads include identification of tethering proteins like Pex3 and seipin partners, metabolic regulation of contact site dynamics, and conserved mechanisms from yeast to mammalian systems. Her work demonstrates increasing methodological sophistication through cryo-EM and live-cell imaging approaches. As supervisor in the CiM-IMPRS Graduate Programme, Bohnert mentors next-generation scientists within the Cells in Motion research environment. Her lab maintains active collaborations with the Multiscale Imaging Centre and participates in the University Hospital Münster's research infrastructure, operating from the Institute of Cell Dynamics and Imaging facility at Von-Esmarch Str. 56.

Ziru Liمشاهده پروفایل

پژوهشگر

• Metabolism
• Bone Biology
• Bone Marrow Adipose Tissue
• +۶ مورد دیگر

Ziru Li is a Faculty Scientist I at the MaineHealth Institute for Research (MHIR) and an affiliated faculty member of the Graduate School of Biomedical Science and Engineering (GSBSE) at the University of Maine. She is actively involved in cutting-edge research on metabolism, bone biology, and bariatric surgery outcomes. Education: Ph.D. in Clinical Medicine, Peking University, 2014 Postdoctoral Training, University of Michigan-Ann Arbor Dr. Li's research focuses on the biological mechanisms of obesity and metabolic regulation, with a particular interest in the gut-bone axis and bone marrow adipose tissue. Her work investigates how bariatric surgeries such as vertical sleeve gastrectomy influence bone density and marrow composition, uncovering key roles for signaling molecules like G-CSF and sclerostin. She employs molecular, genetic, and physiological approaches in mouse models to dissect metabolic pathways involving mTOR, Wnt/β-catenin, and adipocyte lipolysis. Her recent publications reveal a strong trend in understanding how adipose tissues—particularly bone marrow adipocytes—function as active endocrine and metabolic organs. These studies span disciplines including endocrinology, cell biology, and metabolic surgery, highlighting her interdisciplinary approach. Key themes include adipocyte-bone crosstalk, energy homeostasis during caloric deficit, and therapeutic targeting of bone loss post-surgery. Dr. Li has not been mentioned with any scientific awards in the provided text. She mentors graduate students through her affiliation with the GSBSE program, contributing to the training of future biomedical scientists. Her research is supported by collaborative grants, particularly with leading institutions such as the University of Michigan and MaineHealth. She is based at the MHIR facility in Orono, Maine, and maintains active collaborations across the GSBSE network, including the University of New England and The Jackson Laboratory. Dr. Li leads a research laboratory focused on metabolic regulation and bone health, working within a statewide consortium that promotes transdisciplinary innovation in biomedical science.

Charles Burantمشاهده پروفایل

استاد

• Obesity
• Type 2 Diabetes
• Insulin Resistance
• +۵ مورد دیگر

Charles Burant is Professor of Nutritional Sciences at the University of Michigan School of Public Health and holds a professorship in the Section of Metabolism, Endocrinology, and Diabetes within the Medical School's Department of Internal Medicine. He holds the endowed Dr. Robert C. and Veronica Atkins Professor of Metabolism chair. His clinical practice focuses on obesity, type 2 diabetes, and related metabolic disorders at the WK Kellogg Eye Center, Brehm Tower in Ann Arbor. Dr. Burant's research integrates multi-omic approaches (genomics, transcriptomics, proteomics, metabolomics) with clinical and behavioral phenotypes to unravel mechanisms of obesity, insulin resistance, and diabetes. His laboratory investigates pancreatic beta-cell metabolism, insulin secretion dynamics, and adult pancreatic progenitor cells for beta-cell regeneration. As director of the Michigan Metabolomics and Obesity Center (MMOC), he oversees the NIH-funded Nutrition Obesity Research Center and Michigan Regional Comprehensive Metabolomics Resource Core, providing critical infrastructure for metabolic disease research. The MMOC also coordinates the Investigational Weight Management Clinic, which combines clinical care with phenotypic tracking to study diabetes prevention and weight regain mechanisms in formerly obese patients. Analysis of his recent publications reveals dominant themes in multi-omic exercise physiology, causal metabolite-disease relationships, and tissue-specific metabolic adaptations. His work consistently emphasizes sexual dimorphism, temporal dynamics, and molecular mechanisms in metabolic disorders, particularly through large-scale consortia like MoTrPAC. Key focus areas include lipid metabolism in disease contexts, adipose tissue remodeling, and mitochondrial function across tissues. While no specific scientific awards beyond his endowed chair are listed, his leadership of major NIH-funded centers demonstrates significant recognition. His grant portfolio includes infrastructure support through the MMOC, NORC, and Metabolomics Resource Core, enabling extensive human and animal studies in metabolic diseases. Dr. Burant directs the MMOC's integration of research and clinical care through the Investigational Weight Management Clinic. His laboratory maintains active programs in insulin resistance mechanisms using animal models and explores pancreatic progenitor cell applications for diabetes therapy, representing forward-looking approaches to metabolic disease treatment.

• Biochemistry
• Protein Structure and Function
• Lipoprotein Metabolism
• +۳ مورد دیگر

Aivar Lõokene is a distinguished Research Fellow at Tallinn University of Technology's School of Science, Department of Chemistry and Biotechnology, where he has been working since 2017. Previously, he held positions at the Faculty of Science, Department of Chemistry, and has extensive experience in biochemistry and molecular biology research. His academic journey includes significant contributions to the fields of protein structure, lipoprotein metabolism, and enzymology. PhD in Organic Chemistry, Institute of Chemistry, Estonian Academy of Sciences (1990) Chemistry (Bioorganic Chemistry), Tartu State University (1983) Dr. Lõokene's primary research interests focus on biochemistry , particularly protein structure and function and lipoprotein metabolism . His work has significantly contributed to understanding lipoprotein lipase interactions, enzyme regulation, and metabolic pathways. His research methodology often employs advanced techniques including calorimetry, protein interaction studies, and molecular analysis. He has established himself as an expert in lipid metabolism research, with particular focus on the molecular mechanisms of lipoprotein lipase function and regulation. Analysis of Dr. Lõokene's recent publications reveals a consistent focus on lipoprotein lipase and related metabolic processes. His work spans from fundamental protein interactions to clinical applications, demonstrating both depth and breadth in biochemical research. The publications show a progression from basic enzymology to more complex physiological systems, with increasing attention to metabolic disorders and potential therapeutic applications. His research often bridges traditional biochemistry with cutting-edge analytical techniques, particularly calorimetry-based approaches for studying protein interactions. Scholarship of the Swedish Royal Academy (2000) Dr. Lõokene has been actively involved in academic supervision and committee work, serving on defense committees for numerous doctoral theses including those of H. Pupart, E. Kabin, M. Pikta, J. Gavrilova, E. Berntsson, E. Esvald, E. Prigorchenko, A. Koit, A. Klepinin, and M. Sardis. He has also served as an opponent for doctoral defenses by Külliki Varvas, Kaido Viht, and Mihkel Saluri. His administrative contributions include membership in the Estonian Biochemical Society from 2010 to 2025. Dr. Lõokene leads research activities focused on protein biochemistry and metabolism at Tallinn University of Technology. His work environment includes advanced biochemical laboratories equipped for protein interaction studies, enzymatic assays, and molecular analysis. His research group collaborates with international partners, including researchers from Sweden and other European institutions, reflecting the global nature of contemporary biochemical research.

• Genetics
• Endocrinology
• Molecular Biology
• +۳ مورد دیگر

Mara Giordano is an Associate Professor at the University of Eastern Piedmont Amedeo Avogadro's Department of Health Sciences. Her research focuses on genetics, molecular biology, and endocrinology, particularly in growth disorders, genetic polymorphisms, and pediatric endocrinology. She leads projects on retinitis pigmentosa and genetic causes of growth hormone deficiency. Her research interests include studying genetic variants in conditions like obesity, neonatal diabetes mellitus, and thrombotic diseases. She has contributed to understanding the role of genes such as SHOX, GH1, and CAVIN1/PTRF in growth and metabolic disorders. Her work also explores post-COVID-19 immune responses and long-term sequelae. Giordano collaborates internationally on projects like ADPedKD and has published extensively on genetic diagnostics, including the use of next-generation sequencing for growth disorders. She is involved in studies on pharmacogenetics (e.g., dabigatran response) and the interplay between genes and microbiota in autoimmune diseases. Her research has led to advancements in molecular mechanisms of diseases and therapeutic strategies, such as innovative anticoagulation approaches and genotype-guided diabetes management. She has supervised four research works and actively participates in collaborative networks to address genetic and clinical challenges in endocrinology and nephrology. Giordano’s contributions span from basic genetic studies to clinical applications, emphasizing translational research and improving diagnostic tools for rare diseases.

• Calcium Signaling
• Cardiac Physiology
• Excitation-Contraction Coupling
• +۶ مورد دیگر

Rafael Mejia-Alvarez is a Professor at Midwestern University , where he holds appointments in the Chicago College of Optometry , College of Graduate Studies - Illinois , Chicago College of Osteopathic Medicine , and College of Dental Medicine-Illinois . His academic career spans multiple disciplines, including Physiology , Biomedical Sciences , and Cardiovascular Research . Ph.D. from Baylor College of Medicine/CINVESTAV, USA (1990) M.D. from Universidad Nacional Autonoma de Mexico, USA (1982) His research focuses on Calcium Signaling in excitable cells, particularly the mechanisms of Ca²⁺ release via Ryanodine Receptors (RyRs) and Inositol 1,4,5-Trisphosphate Receptors (IP3Rs) . He investigates their roles in cardiac excitation-contraction coupling , arrhythmogenic intracellular channelopathies , and the antiarrhythmic effects of scorpion venom peptides . Techniques include immunocytochemistry , electrophysiology , and pulsed local-field fluorescence microscopy to study intact beating hearts. Recent publications (2023–2005) highlight his work on Ca²⁺ signaling dynamics in cardiac cells, genetic mutations in IP3Rs linked to arrhythmias, and innovations in imaging methodologies . His multidisciplinary approach bridges molecular physiology, pharmacology, and translational medicine. Teaching Interests: Courses include Neuromuscular & Cardiovascular Physiology , Obesity & Cardiovascular Diseases , Cardiac Arrhythmias & Channelopathies , and Precision Medicine in Cardiovascular Systems across multiple academic schools. Grants: Recipient of a 2023 MWU Intramural Grant for research on IP3R2-mediated Ca²⁺ Signaling in Ventricular Myocytes .

• Genetics of Obesity
• Body Fat Distribution
• Metabolic Disorders
• +۴ مورد دیگر

Matt Neville serves as the Oxford Biobank Scientific Coordinator within the Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM) at the University of Oxford's Medical Sciences Division. His primary responsibilities include curation of the Oxford Biobank resources, facilitation of translational research studies, and management of biobank operations. As a Lecturer, he supervises DPhil students and contributes to the Experimental and Translational Therapeutics MSc program. His research focuses on the genetic determinants of body fat function and distribution and their impact on obesity-related health consequences. Neville employs genomic, epigenomic, and metabolomic approaches to investigate adipose tissue biology, metabolic disorders, and Type II diabetes pathogenesis. His work leverages large-scale biobank resources including Oxford Biobank and UK Biobank for translational studies. Analysis of his 15 most recent publications reveals a consistent emphasis on genetic architecture of metabolic traits , with particular attention to adipose tissue biology, obesity genetics, and biomarker discovery. His research integrates multi-omic approaches (genomics, epigenomics, proteomics) to understand context-specific molecular mechanisms in metabolic diseases, with strong translational applications for risk prediction and personalized medicine. Neville holds critical operational roles including Person Designated for the OCDEM HTA license and serves as the RDM OCDEM EDI Champion. His academic journey began with a DPhil in human molecular genetics from Oxford in 2000, followed by industry R&D experience, and a postdoctoral position with Prof Fredrik Karpe since 2003 investigating adipose tissue genetics.

Hongyuan Yangمشاهده پروفایل

استاد

• Molecular Mechanisms of Cellular Lipids
• Lipid Droplet Biogenesis
• Lipid Trafficking and Sorting
• +۶ مورد دیگر

Hongyuan Yang, PhD is a Professor at The University of Texas Health Science Center at Houston (UTHealth Houston), where he leads a research laboratory focused on cellular lipid biology. His work bridges fundamental cell biology with clinical implications for metabolic and degenerative diseases. Education: Bachelor of Medicine from Peking University Health Science Center Ph.D. from Columbia University, New York Dr. Yang's research primarily investigates the molecular mechanisms governing cellular lipid sorting, trafficking, and storage. His laboratory has made seminal contributions to understanding lipid droplet biogenesis, identifying key proteins including seipin, AGPAT2, ORP5, and DFCP1 that regulate lipid droplet formation. His work has demonstrated how lipid droplet biogenesis is intimately linked to adipogenesis and adipose tissue maintenance, with null mutations in seipin or AGPAT2 causing severe congenital generalized lipodystrophy in humans. Additionally, his research explores how lipids are sorted and transported in mammalian cells, with discoveries including ORP2 as a key cholesterol transporter to the plasma membrane and TMEM41B/VMP1 as novel ER scramblases. An analysis of Dr. Yang's recent publications reveals a consistent focus on lipid droplet biogenesis, membrane contact sites, and lipid transport mechanisms. His work spans multiple model systems and connects fundamental cellular processes to human diseases including obesity, diabetes, cardiovascular disease, and neurodegenerative disorders. Notably, several publications demonstrate translational potential, with discoveries leading to the development of new compounds for treating cancer and neurodegenerative disorders. Dr. Yang's laboratory has established itself as a leader in cellular lipid biology, with publications appearing in top-tier journals including Nature Communications, Proceedings of the National Academy of Sciences, Journal of Cell Biology, and Cell. His research program integrates biochemical, cell biological, and genetic approaches to unravel complex lipid-related processes. While specific advising information isn't detailed in the provided text, Dr. Yang's extensive publication record with numerous co-authors suggests an active mentoring program for graduate students and postdoctoral researchers. His laboratory appears well-funded based on the consistent output of high-impact research across multiple years. The Yang laboratory maintains a strong research program investigating the fundamental mechanisms of cellular lipid biology, with particular emphasis on lipid droplet formation and membrane lipid distribution. This work has significant implications for understanding and treating metabolic diseases, with connections to obesity, diabetes, cardiovascular disease, and neurodegeneration.

Elif A Oralمشاهده پروفایل

استاد

• Endocrinology
• Diabetes Research
• Metabolic Disorders
• +۳ مورد دیگر

Elif A Oral is a Professor at the University of Michigan Medical School within the Department of Internal Medicine. Her work bridges clinical research and translational applications in metabolic disorders and endocrinology. Education: MD from Istanbul University Faculty of Medicine (1992), MS in Public Health from University of Michigan (2007). Research interests focus on lipodystrophy, diabetes, and metabolic syndromes, with a particular emphasis on therapeutic innovations like GLP-1 agonists and precision medicine approaches. She also explores interdisciplinary solutions for orthopedic infections through biomaterials engineering. Publications highlight collaborations across endocrinology, infectious diseases, and biomedical engineering, addressing topics such as HIV-related stress responses, implantable drug delivery systems, and genetic biomarkers in metabolic disorders.

Anil Agarwalمشاهده پروفایل

استاد

• Lipodystrophy Research
• Steroid Metabolism
• Genetic Disorders
• +۳ مورد دیگر

Anil Agarwal, Ph.D., is a Professor in the Department of Internal Medicine at UT Southwestern Medical Center, affiliated with the Division of Endocrinology. He joined the faculty in 1994 as a Research Instructor, advancing to Professor by 2012. His research focuses on steroid metabolism, lipodystrophy mechanisms, and genetic disorders, particularly congenital generalized lipodystrophy (CGL) and mandibuloacral dysplasia. Agarwal’s work has identified key genes like AGPAT2 and ZMPSTE24 as critical in lipid storage and metabolic pathways. Education: B.Sc. in Zoology/Chemistry/Botany (University of Allahabad), M.Sc. in Biochemistry (Kanpur University), Ph.D. in Biochemistry (Kanpur University). Postdoctoral fellowships at the Rockefeller University and Central Drug Research Institute. Research Interests: Lipodystrophy pathogenesis and genetic causes Role of AGPAT2 in adipogenesis and metabolic disorders Molecular mechanisms of insulin resistance Progeroid syndromes and laminopathies Enzymatic pathways in lipid metabolism Publications reflect a focus on lipid metabolism, genetic syndromes, and endocrine disorders. Notable contributions include identifying AGPAT2 mutations in CGL and ZMPSTE24 mutations in mandibuloacral dysplasia. Affiliations: Member of the Endocrine Society and American Society for Biochemistry and Molecular Biology. Leads the Agarwal Lab, exploring steroid metabolism and lipodystrophy mechanisms.

• Genetic Disorders
• Metabolic Diseases
• Pediatrics
• +۳ مورد دیگر

Gerard Berry is a Professor of Pediatrics at Harvard Medical School and an Attending Physician in the Division of Genetics and Genomics. He specializes in metabolic and genetic disorders, focusing on conditions like galactosemia, congenital disorders of glycosylation (CDG), and urea cycle disorders. He leads the Galactosemia Network (GalNet), a global registry for patients with galactosemia, and has contributed to international clinical guidelines for managing genetic metabolic diseases. Education: Bachelor's degree in Pre-Med from the University of Notre Dame (1971) M.D. from Jefferson Medical College (1975) Pediatrics residency at Thomas Jefferson University Hospital (1978) Fellowships in Biochemical Genetics and Pediatric Endocrinology at Children's Hospital of Philadelphia (1981) Research Interests: His work centers on understanding and improving treatments for inherited metabolic disorders, including galactosemia, PMM2-CDG, and urea cycle disorders. He investigates long-term complications (e.g., neurodevelopmental outcomes, reproductive health), dietary interventions, and novel therapies like triheptanoin for fatty acid oxidation disorders. He emphasizes translational research, linking molecular mechanisms to clinical care. Publications: Dr. Berry's recent work highlights advancements in galactosemia treatment (e.g., liver transplantation outcomes), CDG natural history studies, and metabolic pathway analysis. His articles often address clinical management strategies and the impact of genetic mutations on disease severity. Affiliations: Director of the Division of Genetics and Genomics at Boston Children's Hospital Member of the GalNet steering committee Principal investigator in NIH-funded studies on metabolic disorders Labs/Teams: He leads a multidisciplinary team focused on metabolic genetics, collaborating with clinicians, geneticists, and biochemists to advance diagnostics and therapies for rare diseases.